B2A as a positive BMP receptor modulator

References

• Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K. 2001. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci. 114:1483–1489.
   PubMed Web of Science ®Google Scholar
• Axelrad TW, Einhorn TA. 2009. Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev. 20:481–488.
   PubMed Web of Science ®Google Scholar
• Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S. 2005. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem. 280:25111–25118.
   PubMed Web of Science ®Google Scholar
• Carragee EJ, Hurwitz EL, Weiner BK. 2011. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 11:471–491.
   PubMed Web of Science ®Google Scholar
• Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 85:1544–1552.
   PubMed Web of Science ®Google Scholar
• Cunningham BW, Atkinson BL, Hu N, Kikkawa J, Jenis L, Bryant J, Zamora PO, McAfee PC. 2009. Ceramic granules enhanced with B2A peptide for lumbar interbody spine fusion: An experimental study using an instrumented model in sheep. J Neurosurg Spine. 10:300–307.
   Google Scholar
• Erlacher L, McCartney J, Piek E, ten Dijke P, Yanagishita M, Oppermann H, Luyten FP. 1998. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J Bone Miner Res. 13:383–392.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Kokabu S, Ohte S, Sasanuma H, Kanomata K, Yoneyama K, Kato H, Akita M, Oda H, Katagiri T. 2010. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differ Res Biol Divers. 80:46–52.
   Google Scholar
• Hassel S, Yakymovych M, Hellman U, Ronnstrand L, Knaus P, Souchelnytskyi S. 2006. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor. J Cell Physiol. 206:457–467.
   Google Scholar
• Heinecke K, Seher A, Schmitz W, Mueller TD, Sebald W, Nickel J. 2009. Receptor oligomerization and beyond: A case study in bone morphogenetic proteins. BMC Biol. 7:59.
   PubMed Web of Science ®Google Scholar
• Honda T, Yamamoto H, Ishii A, Inui M. 2010. PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling. Mol Biol Cell. 21:3269–3277.
   Google Scholar
• Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 127:1755–1766.
   PubMed Web of Science ®Google Scholar
• Keller S, Nickel J, Zhang JL, Sebald W, Mueller TD. 2004. Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol. 11:481–488.
   PubMed Web of Science ®Google Scholar
• Kenakin T. 2007. Allosteric agonist modulators. J Recept Signal Transduction Res. 27:247–259.
   PubMed Web of Science ®Google Scholar
• Kirsch T, Nickel J, Sebald W. 2000. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19:3314–3324.
   PubMed Web of Science ®Google Scholar
• Komiya Y, Habas R. 2008. Wnt signal transduction pathways. Organogenesis. 4:68–75.
   PubMedGoogle Scholar
• Liao JC, Tzeng ST, Keorochana G, Lee KB, Johnson JS, Morishita Y, Murray SS, Wang JC. 2011. Enhancement of recombinant human BMP-7 bone formation with bmp binding peptide in a rodent femoral defect model. J Orthopaedic Res. 29:753–759.
   PubMed Web of Science ®Google Scholar
• Lin X, Elliot JJ, Carnes DL, Fox WC, Peña LA, Campion SL, Takahashi K, Atkinson BL, Zamora PO. 2007. Augmentation of osseous phenotypes in vivo with a synthetic peptide. J Orthop Res. 25:531–539.
   Google Scholar
• Lin J, Patel SR, Cheng X, Cho EA, Levitan I, Ullenbruch M, Phan SH, Park JM, Dressler GR. 2005. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med. 11:387–393.
   PubMedGoogle Scholar
• Lin X, Zamora PO, Albright S, Glass JD, Pena LA. 2005. Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro. J Bone Miner Res. 20:693–703.
   PubMed Web of Science ®Google Scholar
• Marom B, Heining E, Knaus P, Henis YI. 2011. Formation of stable homomeric and transient heteromeric bone morphogenetic protein (BMP) receptor complexes regulates Smad protein signaling. J Biol Chem. 286:19287–19296.
   Google Scholar
• Minear S, Leucht P, Jiang J, Liu B, Zeng A, Fuerer C, Nusse R, Helms JA. 2010. Wnt proteins promote bone regeneration. Sci Transl Med. 2:29–30.
   Google Scholar
• Morishita Y, Naito M, Miyazaki M, He W, Wu G, Wei F, Sintuu C, Hymanson H, Brochmann EJ, Murray SS, Wang JC. 2010. Enhanced effects of BMP-binding peptide combined with recombinant human BMP-2 on the healing of a rodent segmental femoral defect. J Orthopaedic Res Off Publ Orthopaedic Res Soc. 28:258–264.
   Google Scholar
• Mroz TE, Joyce MJ, Lieberman IH, Steinmetz MP, Benzel EC, Wang JC. 2009. The use of allograft bone in spine surgery: Is it safe?. Spine J. 9:303–308.
   Google Scholar
• Mroz TE, Wang JC, Hashimoto R, Norvell DC. 2010. Complications related to osteobiologics use in spine surgery: A systematic review. Spine (Phila Pa 1976). 35:S86–104.
   Google Scholar
• Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T. 1997. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem. 272:22046–22052.
   PubMedGoogle Scholar
• Nickel J, Dreyer MK, Kirsch T, Sebald W. 2001. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am. 83-A Suppl. 1: S7–S14.
   PubMedGoogle Scholar
• Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T. 1998. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem. 273:1872–1879.
   PubMed Web of Science ®Google Scholar
• Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K. 1996. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem. 271:21345–21352.
   PubMed Web of Science ®Google Scholar
• Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem. 277:5330–5338.
   PubMed Web of Science ®Google Scholar
• Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S. 1999. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun. 262:739–743.
   Google Scholar
• Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res Off J Am Soc Bone Miner Res. 18:1842–1853.
   PubMed Web of Science ®Google Scholar
• Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, Stricker S, Pohl J, Plöger F, Staub E, Nickel J, Sebald W, Knaus P, Mundlos S. 2005. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest. 115:2373–2381.
   PubMed Web of Science ®Google Scholar
• Smucker JD, Bobst JA, Petersen EB, Nepola JV, Fredericks DC. 2008. B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft. Spine. 33:1324–1329.
   PubMed Web of Science ®Google Scholar
• Song HM, Nacamuli RP, Xia W, Bari AS, Shi YY, Fang TD, Longaker MT. 2005. High-dose retinoic acid modulates rat calvarial osteoblast biology. J Cell Physiol. 202:255–262.
   PubMed Web of Science ®Google Scholar
• Taghavi CE, Lee KB, He W, Keorochana G, Murray SS, Brochmann EJ, Uludag H, Behnam K, Wang JC. 2010. Bone morphogenetic protein binding peptide mechanism and enhancement of osteogenic protein-1 induced bone healing. Spine. 35:2049–2056.
   Google Scholar
• Vaidehi N, Kenakin T. 2010. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol. 10:775–781.
   PubMed Web of Science ®Google Scholar
• Wan DC, Shi YY, Nacamuli RP, Quarto N, Lyons KM, Longaker MT. 2006. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Nat Acad Sci USA. 103:12335–12340.
   PubMed Web of Science ®Google Scholar
• Weber D, Kotzsch A, Nickel J, Harth S, Seher A, Mueller U, Sebald W, Mueller TD. 2007. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct Biol. 7:6.
   PubMedGoogle Scholar